🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.2522
+0.0393 (18.46%)
Nov 20, 2026, 9:55 AM EST - Market open

LABT Statistics

Total Valuation

LABT has a market cap or net worth of $2.26 million. The enterprise value is -$994,991.

Market Cap2.26M
Enterprise Value -994,991

Important Dates

The last earnings date was Monday, November 16, 2026, after market close.

Earnings Date Nov 16, 2026
Ex-Dividend Date n/a

Share Statistics

LABT has 8.95 million shares outstanding. The number of shares has increased by 87.70% in one year.

Current Share Class 8.95M
Shares Outstanding 8.95M
Shares Change (YoY) +87.70%
Shares Change (QoQ) +68.08%
Owned by Insiders (%) 13.55%
Owned by Institutions (%) 2.83%
Float 7.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.27
P/TBV Ratio 0.65
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.02.

Current Ratio 5.22
Quick Ratio 4.94
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -79.61

Financial Efficiency

Return on equity (ROE) is -833.72% and return on invested capital (ROIC) is -252.22%.

Return on Equity (ROE) -833.72%
Return on Assets (ROA) -350.75%
Return on Invested Capital (ROIC) -252.22%
Return on Capital Employed (ROCE) -235.86%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 0.80
200-Day Moving Average n/a
Relative Strength Index (RSI) 36.52
Average Volume (20 Days) 44,651,099

Short Selling Information

The latest short interest is 152,917, so 1.71% of the outstanding shares have been sold short.

Short Interest 152,917
Short Previous Month 90,040
Short % of Shares Out 1.71%
Short % of Float 2.06%
Short Ratio (days to cover) 0.04

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.90M
Pretax Income -6.91M
Net Income -8.04M
EBITDA -6.89M
EBIT -6.90M
Earnings Per Share (EPS) -$6.16
Full Income Statement

Balance Sheet

The company has $3.32 million in cash and $71,433 in debt, with a net cash position of $3.25 million or $0.36 per share.

Cash & Cash Equivalents 3.32M
Total Debt 71,433
Net Cash 3.25M
Net Cash Per Share $0.36
Equity (Book Value) 2.93M
Book Value Per Share 0.80
Working Capital 2.84M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.14M
Capital Expenditures n/a
Depreciation & Amortization 4,634
Net Borrowing n/a
Free Cash Flow -4.14M
FCF Per Share -$0.46
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LABT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -87.70%
Shareholder Yield -87.70%
Earnings Yield -2,440.71%
FCF Yield -217.10%

Analyst Forecast

Price Target $7.50
Price Target Difference 2,873.83%
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on June 22, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date Jun 22, 2026
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 2